Non-alcoholic fatty liver disease (NAFLD) affects 25% of adults and at present no licensed medication has been approved. Despite its complex patho-physiology, dietary strategies aiming at delaying or preventing NAFLD have taken a reductionist approach, examining the impact of single components. Accumulating evidence suggests that n-3 LC-PUFAs are efficacious in regulating lipogenesis and fatty acid oxidation. In addition, plant derived flavonoids are also emerging as a dietary strategy for NAFLD prevention, with efficacy attributed to their insulin sensitising and indirect antioxidant effects. Based on knowledge of their complementary molecular targets, we aimed to demonstrate that the combination of n-3 LC-PUFA (n-3) and flavan-3-ols (FLAV...
Non-alcoholic fatty liver disease (NAFLD) covers a spectrum of disorders ranging from simple steatos...
Non-alcoholic fatty liver disease (NAFLD) is currently considered the most common liver disease in i...
Scope Higher flavonoid intake is associated with reduced risk of non-alcoholic fatty liver diseas...
Non-alcoholic fatty liver disease (NAFLD) affects 25% of adults and at present no licensed medicatio...
P. 2991-3012Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of metabolic syndro...
P. 2991-3012Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of metabolic syndro...
Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease ...
The contemporary pathophysiological model of non-alcoholic fatty liver disease (NAFLD) consists of m...
The contemporary pathophysiological model of non-alcoholic fatty liver disease (NAFLD) consists of m...
The contemporary pathophysiological model of non-alcoholic fatty liver disease (NAFLD) consists of m...
The contemporary pathophysiological model of non-alcoholic fatty liver disease (NAFLD) consists of m...
SummaryNon-alcoholic fatty liver disease (NAFLD) is associated with the growing incidence of metabol...
Non-alcoholic fatty liver disease (NAFLD) is a clinical condition characterized by lipid infiltratio...
Non-alcoholic fatty liver disease (NAFLD) is a clinical condition characterized by lipid infiltratio...
Non-alcoholic fatty liver disease (NAFLD) ranges from steatosis and hepatic insulin resistance to no...
Non-alcoholic fatty liver disease (NAFLD) covers a spectrum of disorders ranging from simple steatos...
Non-alcoholic fatty liver disease (NAFLD) is currently considered the most common liver disease in i...
Scope Higher flavonoid intake is associated with reduced risk of non-alcoholic fatty liver diseas...
Non-alcoholic fatty liver disease (NAFLD) affects 25% of adults and at present no licensed medicatio...
P. 2991-3012Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of metabolic syndro...
P. 2991-3012Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of metabolic syndro...
Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease ...
The contemporary pathophysiological model of non-alcoholic fatty liver disease (NAFLD) consists of m...
The contemporary pathophysiological model of non-alcoholic fatty liver disease (NAFLD) consists of m...
The contemporary pathophysiological model of non-alcoholic fatty liver disease (NAFLD) consists of m...
The contemporary pathophysiological model of non-alcoholic fatty liver disease (NAFLD) consists of m...
SummaryNon-alcoholic fatty liver disease (NAFLD) is associated with the growing incidence of metabol...
Non-alcoholic fatty liver disease (NAFLD) is a clinical condition characterized by lipid infiltratio...
Non-alcoholic fatty liver disease (NAFLD) is a clinical condition characterized by lipid infiltratio...
Non-alcoholic fatty liver disease (NAFLD) ranges from steatosis and hepatic insulin resistance to no...
Non-alcoholic fatty liver disease (NAFLD) covers a spectrum of disorders ranging from simple steatos...
Non-alcoholic fatty liver disease (NAFLD) is currently considered the most common liver disease in i...
Scope Higher flavonoid intake is associated with reduced risk of non-alcoholic fatty liver diseas...